Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Ndhlovu LC, Giron LB, Galinskas J, Premeaux TA, Pang APS, Dias D, de Almeida Baptista MV, Shytaj IL, Maricato JT, Ferreira PRA, Gosuen G, Corley MJ, Friday CM, Bowler SA, Della Libera E, Sucupira MC, Hunter JR, Janini LM, Schechter M, Savarino A, Diaz RS. Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV. J Infect Dis. 2025 Nov 14; 232(5):1067-1077.
-
Baskaran P, Aldhaeefi M, Asaadi A, Jones M, King E, Rungkitwattanakul D, Wingate L. Empagliflozin and hydralazine-isosorbide dinitrate combination therapy improves outcomes in Black patients with heart failure. Int J Clin Pharmacol Ther. 2025 Nov; 63(11):553-556.
-
Besharati S, Mohammadzadeh V, Ashrafkhorasani M, Mahmoudinezhad G, Hu Z, Rafiei M, Guerrero A, Figueroa J, Coleman AL, Giaconi J, Law SK, Fei Z, Caprioli J, Nouri-Mahdavi K. Outcomes of Trabeculectomy With Mitomycin C in Patients of Hispanic vs European Descent. JAMA Ophthalmol. 2025 Oct 01; 143(10):813-821.
-
Nishida C, Shimoda B, Weldon RH, Kaneshiro JM, Nakasone CK. Alignment and early clinical outcomes following total knee arthroplasty using a handheld navigation system compared to conventional instruments. Arch Orthop Trauma Surg. 2025 Sep 02; 145(1):434.
-
Papapostolou S, Kearns JS, Costello B, O'Brien J, Gutman S, Nanayakkara S, Kaye DM, Walton A, Hare J, Stub D, Taylor A. Relationship between left ventricular wall stress and cardiac remodelling post-TAVR and MitraClip. Open Heart. 2025 Aug 31; 12(2).
-
McNamara PJ, Chock VY, Rahde-Bischoff A, Gabrio J, Johnson KJ, Harmon HM, Montoya-Williams D, Colaizy TT, Katheria AC, Ines F, Sorrells K, Battersby C, Levy PT, Rysavy MA, Bhombal S, Laughon MM, Carper B, Hintz SR, Das A, Bell EF. Evaluating the efficacy and safety of milrinone for prevention of post-patent ductus arteriosus closure syndrome (the MIDAS trial) in extremely preterm infants: a multicentre, double-masked, randomised, placebo-controlled trial. BMJ Open. 2025 Aug 26; 15(8):e105018.
-
Warren J, Ball J, Dawson L, Nehme E, Mahony E, Nanayakkara S, Chew DP, Kaye DM, Taylor A, Nehme Z, Stub D. Incidence and Predictors of Referral for Coronary Angiography and Revascularization in Non-ST-Segment Elevation Myocardial Infarction. Catheter Cardiovasc Interv. 2025 Oct; 106(4):2713-2723.
-
Patel R, Fukui J, Klein P, Moshier E, Kocyigit H, Fiedler L, Bucwinska W, Xing XY, Shapiro C, Goel A, Fasano J, Shao T, Bhardwaj A, Kim E, Vaccaro R, Lee K, Wilck E, Tiersten A. Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer. Breast Cancer Res Treat. 2025 Nov; 214(2):159-170.
-
Grbac AJ, Naimo PS, Russo JJ, Fogarty SJ, Wilson WM, Zentner D, English KM, Grigg LE, Taylor AJ, Lui EH, Joshi SB, Lee MGY. High variability in reporting of right ventricle contouring technique and body surface area methodology in cardiac magnetic resonance studies of patients with repaired tetralogy of Fallot: A systematic review. J Cardiovasc Magn Reson. 2025 Winter; 27(2):101942.
-
L?pez-Castro T, Gette JA, Back SE, Blakey SM, Killeen TK, Morgan-Lopez AA, Norman SB, Ruglass LM, Saavedra LM, McGovern MP, Petrakis IL, Sonne S, Ehring T, Brady KT, Hien DA. World Health Organization risk drinking level reductions as treatment outcomes in PTSD and substance use disorder trials. Drug Alcohol Depend. 2025 Oct 01; 275:112837.